Dartmouth-Hitchcock logo
Summer Flowers In This Section

About the Program

The goal of the Cerebrovascular Disease and Stroke Program is to provide the highest quality, evidenced-based care for patients and families dealing with stroke, transient ischemic attack, and other cerebrovascular conditions, including brain aneurysms and vascular malformations.

Inpatient care is based in the Neuroscience Unit at Dartmouth-Hitchcock, which includes a ten-bed Neuro Special Care Unit with specialty trained nursing staff. Our cutting edge diagnostic capabilities include MRI and MRA, MR perfusion, conventional (digital subtraction) angiography, among other diagnostic tests. We are actively engaged in clinical research and are participating in the NIH-sponsored stroke prevention trials including POINT (Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial, and CREST-2 (Carotid Revascularization Endarterectomy versus Stenting Trial).  Recent program highlights include opening of the Clinical Decision Unit to evaluate patients with transient ischemic attack (December 2014), developing simulation lab training for resident physicians, and launching the first tele-stroke service in the region.

Specific goals for our program include: becoming recognized as a comprehensive center for cerebrovascular care and the regional "hub" of a stroke network that shares resources and improves access to high-quality and cost-effective care for patients in our region, participating in the best clinical trials in our field, bringing relevant basic science and translational research to DHMC, and being a resource for the education of residents, medical students, nurses, primary care providers, and other specialists.

The Cerebrovascular Disease and Stroke Program members strive to meet the needs of stroke patients and their caregivers across the entire continuum of care. We aim to decrease the occurrence of stroke and its complications in the population we serve and advance the field of Cerebrovascular disease care.

Get with the Guidelines Target: Stroke Honor Roll Silver Award

Get with the Guidelines® Target: Stroke Honor Roll Silver Award

The American Heart Association and American Stroke Association recognize this hospital for achieving 85% or higher compliance with all Get With The Guidelines®-Stroke Achievement Measures for 12 consecutive months and achieving Time to Intravenous Thrombolytic Therapy ≤ 60 minutes in 50% or more of applicable acute ischemic stroke patients to improve quality of patient care and outcomes.

Contact Us